Myelodysplastic Syndromes and Myeloproliferative Neoplasms


Share

Program Content

Activities

  • Conference to Clinic MDS 2024
    CCO’s Conference to Clinic Highlights From ASH 2024 Annual Meeting: MDS
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 16, 2025

    Expires: July 15, 2025

Activities

COMMANDS Luspatercept
COMMANDS: Long-term Outcomes of the Phase III Trial of Luspatercept vs Epoetin alfa for ESA-Naive, Transfusion-Dependent, Lower-Risk MDS
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2024

Expires: December 08, 2025

GFM COMBOLA
GFM COMBOLA Part A: Phase I/II Study of Luspatercept + EPO in Patients With Lower-Risk, Ring Sideroblast–Negative MDS After ESA Failure
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2024

Expires: December 09, 2025

IMerge Pooled Analysis
IMerge Pooled Analysis: Effect of Previous Treatments on Imetelstat Activity in RBC Transfusion–Dependent LR-MDS Relapsed/Refractory to ESAs
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2024

Expires: December 09, 2025

Early vs Late ESA for Anemia in Lower Risk MDS
EPO-PRETAR: Phase III Trial of Early vs Late Initiation of ESA Treatment in Patients With Lower-Risk MDS and Anemia
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2024

Expires: December 09, 2025

BOREAS
BOREAS: Phase III Trial of Navtemadlin vs Best Available Therapy in Patients With JAK Inhibitor R/R Myelofibrosis
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2024

Expires: December 10, 2025

DAC + ATRA for MDS EB
Decitabine Plus ATRA for Newly Diagnosed MDS With Excessive Blasts
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2024

Expires: December 15, 2025

Faculty

cover img faculity

Rami Komrokji, MD

Vice Chair of Malignant Hematology Department
Senior Member and Professor of Oncologic Sciences
H. Lee Moffitt Cancer Center
University of South Florida
Tampa, Florida

cover img faculity

Amer Zeidan, MBBS, MHS

Professor of Medicine
Chief, Division of Hematologic Malignancies​
Yale Comprehensive Cancer Center and Smilow Cancer Hospital​
New Haven, Connecticut

Provided by

ProCE Banner

Supporters

This educational activity is supported by independent medical educational grants from AstraZeneca, Bristol Myers Squibb, GlaxoSmithKline, Incyte Corporation, Lilly, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Bristol Myers Squibb

GlaxoSmithKline

Incyte Corporation

Lilly

Novartis Pharmaceuticals Corporation